Last reviewed · How we verify
NCT03547843: ADHD
The Effects of Peer Co-led Educational Group Intervention for Adults With Attention-Deficit Hyperactivity Disorder
NA trial testing Group-based education in Attention Deficit Disorder With Hyperactivity in 56 participants. Completed in 15 March 2020.
15 March 2020
Quick facts
| Lead sponsor | Norwegian University of Science and Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 56 |
| Start date | 31 May 2018 |
| Primary completion | 15 March 2020 |
| Estimated completion | 15 March 2020 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Group-based education
- Waiting list
- Standard treatment
Conditions studied
- Attention Deficit Disorder With Hyperactivity — all drugs for Attention Deficit Disorder With Hyperactivity →
Sponsor
Norwegian University of Science and Technology
Who can join
Adults 18 to 67, any sex, with Attention Deficit Disorder With Hyperactivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Peer co-led education describes educators who are expert patients, user representatives or former patients, participating and teaching in educational interventions in cooperation with health care professionals. Peer co-led education is included in the Norwegian national guidelines for treatment of mental disorders, but despite some promising results for the treatment of other conditions, still little is known about the efficacy of peer co-led educational group interventions interventions for adults with attention deficit and hyperactivity disorder (ADHD). This pilot trial will evaluate patient satisfaction with and preliminary efficacy of a 2-session peer co-led educational group program designed to address specific challenges faced by adults diagnosed with ADHD at an outpatient clinics in mid-Norway.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pilot randomised controlled trial on the feasibility and intervention satisfaction with an educational group programme for adults with attention deficit hyperactivity disorder and their caregivers.
Skliarova T, Gråwe RW, Vaag J, Mandahl A, et al · · 2025 · cited 2× · PMID 39979888 · DOI 10.1186/s12888-025-06570-4
Verify or expand the search:
- PubMed search for NCT03547843
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Attention Deficit Disorder With Hyperactivity
Currently open trials in the same condition.
- NCT06974136 — tES Modalities for the Treatment of ADHD · NA · recruiting
- NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
- NCT05621174 — The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD · NA · active not recruiting
- NCT06369714 — Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. · NA · recruiting
- NCT00001246 — Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers · active not recruiting
Other Norwegian University of Science and Technology trials
Trials by the same sponsor.
- NCT07521891 — Socket-leg Interface Movements in Transtibial Amputees · NA · not yet recruiting
- NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting
- NCT07422597 — Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost · NA · recruiting
- NCT06558851 — The Effect of Systematic Endurance Training in Treatment of Women With Lipedema · NA · active not recruiting
- NCT06893874 — A Pragmatic Trial of Machine Prescription for Migraine · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03547843 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Norwegian University of Science and Technology
- Last refreshed: 27 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03547843.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing